Champions Oncology (CSBR) Assets Average (2011 - 2026)

Champions Oncology's Assets Average history runs 16 years deep, the most recent figure standing at $29.3 million for Q1 2026.

• In Q1 2026, Assets Average rose 4.91% year-over-year to $29.3 million; the TTM figure through Jan 2026 stood at $29.3 million (up 4.91% YoY), while the FY2025 annual figure was $29.2 million, down 3.25% from the prior year.
• Assets Average was $29.3 million for Q1 2026 at Champions Oncology, down from $30.4 million in the prior quarter.
• In the past five years, Assets Average ranged from a high of $36.3 million in Q1 2023 to a low of $25.1 million in Q4 2024.
• Historically, Assets Average has averaged $30.8 million across 5 years, with a median of $31.4 million in 2022.
• The sharpest annual moves came in 2022 and 2024: Assets Average jumped 30.48% in 2022, then declined 24.9% in 2024.
• A 5-year view of Assets Average shows it stood at $35.4 million in 2022, then decreased by 17.74% to $29.1 million in 2023, then retreated by 13.79% to $25.1 million in 2024, then climbed by 21.0% to $30.4 million in 2025, then declined by 3.46% to $29.3 million in 2026.
• The last three Assets Average figures came in at $29.3 million (Q1 2026), $30.4 million (Q4 2025), and $31.4 million (Q3 2025), per Business Quant data.